American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
OP
Option Therapeutics Inc.
$9.60
-1.13%
OPTN · 15-min delayed
OPTNListed
About Option Therapeutics Inc.
Option Therapeutics Inc. is an American company based in CARSON CITY, Nevada.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Listed: OPTN
$9.60
-1.13%
15-minute delayed · data by Polygon.io
Past year
$9.38
$9.71
52-week range
- EPS (diluted)
- $-2.12
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Revenue grew 59% from FY2020 to FY2024.
- Gross margin of 90.8%, net margin -27.5%.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Option Therapeutics Inc..
Write a review
Newsroom
News about Option Therapeutics Inc.
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF
Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors
News & sentiment via Polygon.io
Explore
Browse all →
